Company Filing History:
Years Active: 2017
Title: Mark D McKee: Innovator in Cancer Treatment
Introduction
Mark D McKee is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of oncology, particularly in the treatment of non-small cell lung cancer. His innovative approach combines established chemotherapy agents with novel compounds to enhance treatment efficacy.
Latest Patents
Mark D McKee holds a patent for his invention titled "Veliparib in combination with carboplatin and paclitaxel for the treatment of non-small cell lung cancer in smokers." This patent describes a method for treating non-small cell lung cancer in smokers by administering an effective amount of veliparib, in combination with carboplatin and paclitaxel. This innovative treatment strategy aims to improve outcomes for patients suffering from this challenging disease.
Career Highlights
Mark D McKee is associated with AbbVie Inc., a leading global biopharmaceutical company. His work at AbbVie has focused on developing advanced therapies for cancer treatment, showcasing his commitment to improving patient care through innovative solutions.
Collaborations
Throughout his career, Mark has collaborated with esteemed colleagues, including Vincent L Giranda and Gary B Gordon. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in cancer research.
Conclusion
Mark D McKee's contributions to cancer treatment exemplify the impact of innovation in medicine. His work continues to inspire advancements in therapeutic strategies for non-small cell lung cancer, ultimately benefiting patients and the medical community.